RDC 944/2024
Lot release procedure for vaccines and heterologous hyperimmune sera
Current edition
RDC 944 of November 28, 2024 (in force)
Current edition
RDC 944 of November 28, 2024 (in force)
About this standard
Recognition by market
Whether the market recognizes, harmonizes or adopts this standard, and which edition it accepts
No market listing is published yet.
Testing requirements that cite it
Open the market page and its pathway pages for the full requirement, protocol and report content
Brazil
- Lot release of vaccines and hyperimmune sera by the national control laboratory INCQSLot release and sample testing · Sample testing
Related standards: MHRA Responsible Person (import) guidance, EudraLex Volume 4 Annex 16, HC Lot Release Program guidance, TGA vaccine batch release, MFDS imported drug management regulation, MFDS national lot release regulation, RDC 669/2022, RDC 670/2022, RDC 900/2024, SFDA lot release policy, Taiwan biological product lot release regulations. See all standards.